AstraZeneca’s head of R&D for oncology dies at 61

imageStock Markets5 hours ago (Mar 21, 2021 19:00)

© Reuters.

(Reuters) – AstraZeneca (NASDAQ:AZN) Plc’s head of oncology research, Jose Baselga, has died at the age of 61, the company said on Sunday.

“An outstanding scientific leader, José leaves a lasting legacy in the scientific community and here at AstraZeneca,” the company’s Chief Executive Officer Pascal Soriot said https:// in a statement.

The statement did not give a cause of death but Spanish newspaper La Vanguardia said Baselga had died of Creutzfeldt-Jakob disease, a rare brain condition.

Baselga joined AstraZeneca in 2019. He previously worked as Memorial Sloan Kettering Cancer Center’s chief medical officer. He had also been chief of hematology/oncology at the Massachusetts General Hospital Cancer Center and a professor at Harvard Medical School.

AstraZeneca’s head of R&D for oncology dies at 61

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Please enter your comment!
Please enter your name here